Home
>
National Drug Code (NDC)
>
Vyvanse
Vyvanse - 54868-5916-1 - (lisdexamfetamine dimesylate)
Drug Information of Vyvanse
| Product NDC: | 54868-5916 |
| Proprietary Name: | Vyvanse |
| Non Proprietary Name: | lisdexamfetamine dimesylate |
| Active Ingredient(s): | 30 mg/1 & nbsp; lisdexamfetamine dimesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vyvanse
| Product NDC: | 54868-5916 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021977 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080711 |
Package Information of Vyvanse
| Package NDC: | 54868-5916-1 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (54868-5916-1) |
NDC Information of Vyvanse
| NDC Code | 54868-5916-1 |
| Proprietary Name | Vyvanse |
| Package Description | 30 CAPSULE in 1 BOTTLE (54868-5916-1) |
| Product NDC | 54868-5916 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lisdexamfetamine dimesylate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080711 |
| Marketing Category Name | NDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | LISDEXAMFETAMINE DIMESYLATE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
